Floatz logo

Therapeutic Asset Ratings

6,371 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Teclistamab
Plasma Cell Myeloma
Anne Louise Tølbøll SørensenP4BB (66)
Tislelizumab
Breast Cancer
National University Hospital, SingaporeP4BB (66)
Tislelizumab
Non-small Cell Lung Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd.P4BB (66)
AK105
Hepatocellular Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.P3BB (66)
Amrecibart
Atrial Fibrillation
Regeneron PharmaceuticalsP3BB (66)
Atezolizumab
Castration-Resistant Prostate Carcinoma
Cancer Research UKP3BB (66)
Blinatumomab
Acute Lymphoblastic Leukemia
M.D. Anderson Cancer CenterP3BB (66)
Blinatumomab
B Lymphoblastic Lymphoma
Children's Oncology GroupP3BB (66)
Blinatumomab
Down Syndrome
National Cancer Institute (NCI)P3BB (66)
Cenvacibart
Atrial Fibrillation
Regeneron PharmaceuticalsP3BB (66)
Cetuximab
Head And Neck Cancer
PfizerP3BB (66)
Concizumab
Hemophilia B
Novo Nordisk A/SP3BB (66)
Divozilimab
Multiple Sclerosis
BiocadP3BB (66)
Durvalumab
Small Cell Lung Carcinoma
PrECOG, LLC.P3BB (66)
Girentuximab
Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty LimitedP3BB (66)
Gls-010
Classic Hodgkin Lymphoma
Guangzhou Gloria Biosciences Co., Ltd.P3BB (66)
Humax-Cd20
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
PETHEMA FoundationP3BB (66)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Triple-Negative Breast Carcinoma
Fudan UniversityP3BB (66)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
HR+ Breast Cancer
Tianjin Medical University Cancer Institute and HospitalP3BB (66)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
National Cancer Institute (NCI)P3BB (66)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Juvenile Myelomonocytic Leukemia
Masonic Cancer Center, University of MinnesotaP3BB (66)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Leukemia
University of ChicagoP3BB (66)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Richter Transformation
SWOG Cancer Research NetworkP3BB (66)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
Skin Squamous Cell Carcinoma
Regeneron PharmaceuticalsP3BB (66)
immunoglobulin (H-gamma1_L-kappa)_scFvkh-G1(h-CH2-CH3), anti-[Homo sapiens KLK2 (kallikrein-2, kallikrein related peptidase 2, kallikrein 2 prostatic) and anti-[Homo sapiens CD3E (CD3 epsilon, Leu-4)], Homo sapiens and humanized monoclonal antibody, bispecific, bivalent
Castration-Resistant Prostate Carcinoma
Janssen Research & Development, LLCP3BB (66)
Showing 251 to 275 of 6,371 assets
PreviousPage 11 of 255Next